Bank Of America Corp Imara Inc. Transaction History

Bank Of America Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$3.73 - $5.2 $857 - $1,196	230 New	230 $0
Q1 2022 May 16, 2022	SELL	$1.15 - $2.41 $10,899 - $22,841	-9,478 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$2.25 - $4.05 $267 - $481	119 Added 1.27%	9,478 $21,000
Q3 2021 Nov 15, 2021	SELL	$4.08 - $7.83 $25,618 - $49,164	-6,279 Reduced 40.15%	9,359 $38,000
Q2 2021 Sep 13, 2021	BUY	$6.78 - $9.04 $106,025 - $141,367	15,638 New	15,638 $124,000

104K

170K

Ticker IMRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,287,300
Market Cap $552M
Description
IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develop...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.